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Key Clinical Message
A patient with syndromic Duane retraction syndrome harbors a chromosome
811.1q13.2 inversion and 8p11.1-q12.3 marker chromosome containing subregions with differing mosaicism and allele frequencies. This case highlights the
potential requirement for multiple genetic methods to gain insight into genotype–phenotype correlation, and ultimately into molecular mechanisms that
underlie human disease.
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Introduction
Duane retraction syndrome (DRS) occurs in approximately 1 in 1000 individuals and most commonly manifests as limited abduction with globe retraction on
attempted adduction. It is believed to result from errors
in the development of the abducens nucleus or nerve, and
aberrant innervation of the lateral rectus muscle by axons
of the oculomotor nerve. While dominant DRS pedigrees
30

can harbor mutations in alpha-chimerin (CHN1) [1] or
Sal-like protein 4 (SALL4), [2, 3] most cases of DRS are
simplex and genetically undefined. For almost two decades, rare patients with simplex, syndromic DRS have
been reported to harbor cytogenetic abnormalities in the
chromosomal region 8q12-8q13 that define the DURS1
locus, as summarized below and in Figure 1.
The initial three patients that defined the DURS1 locus
harbored a deletion or had a translocation breakpoint at
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Figure 1. Schematic of the DURS1 region. Horizontal lines at the top of the page indicate cytogenetic bands 8q12.1-8q13.2. Under these bands
are genes in the region as per the UCSC Genome Browser hg 19 (genome.ucsc.edu). Previous reports of duplications (blue) and deletions (red)
are indicated by horizontal lines at the bottom of the figure, and labeled according to the first author and year of the corresponding report. The
previously reported translocation breakpoint disrupting CPA6 is denoted by a vertical light blue line. The mosaic duplication and the translocation
breakpoint found in the patient in the current report are denoted by a green horizontal and green vertical line, respectively. An arrow at the end
of a horizontal line denotes that the deletion or duplication extends further in the indicated direction.

8q13. The first patient had DRS, branchiootorenal syndrome, hydrocephalus, trapezius muscle aplasia, and a
large de novo interstitial deletion del(8)(q13.1-q21.11)
originating on the paternal allele [4]. The second patient
had bilateral DRS type 1, severe intellectual disabilities,
microcephaly, dysmorphisms, brachydactyly and left club
foot, and harbored an insertion of 8q11.2-q13 into 6q25
with a deletion, del(8)(q12.3q13.2) [5]. The third patient
had DRS, dysgenetic gonads, hypoplastic external genitalia
and glandular hypospadias, and a de novo reciprocal
translocation t(6;8)(q26;q13) with the chromosome 8q13
translocation breakpoint located within intron 1 of carboxypeptidase A6 (CPA6) [6, 7]. Notably, a fourth patient with
branchiootorenal syndrome but not DRS is reported to
harbor a deletion from distal 8q13.1 through 8q21.13 [8].
Recently, three patients with DRS were reported to harbor 8q12 microduplications [9–11]. Their phenotypes
included DRS, sensorineural deafness, intellectual disabilities, hypotonia, dysmorphisms, and congenital heart and
kidney defects [9–11]. The three patients share a 1.2 Mb
duplicated region encompassing carbonic anhydrase VIII
(CA8), RAS-associated protein RAB2 (RAB2A), chromodomain helicase DNA binding protein 7 (CHD7), and
clavesin 1 (CLVS1) (Fig. 1). A fourth patient harboring a
2.7 Mb 8q12 microduplication also encompassing these
four genes had dysmorphic features, congenital heart
defect, and torticollis, but did not exhibit DRS [12].
In this study, we describe a boy with syndromic DRS
and complex structural variations involving both 8q12
and 8q13.

ª 2013 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Material and Methods
Participant enrollment
The proband and his maternal grandmother participated
in an ongoing genetic study of DRS at Boston Children’s
Hospital, and provided written informed consent to a
protocol conforming to the Declaration of Helsinki and
approved by Boston Children’s Hospital institutional
review board. The parents of the proband were not available for participation. Medical and ophthalmologic history and physical examination findings were obtained
from medical records. Both participants provided a blood
sample for DNA extraction, and the proband also provided a sample for cell line generation.

Cell line generation
Epstein-Barr virus transformation was performed by the
Biosample Services Facility at Partners Center for Personalized Genetic Medicine, Cambridge MA, for initiation of
a lymphoblastoid cell line.

Probe preparation for fluorescence in situ
hybridization
Bacterial artificial chromosome (BAC) clones were
selected using University of California, Santa Cruz
(UCSC) genome browser (http://genome.ucsc.edu; hg19)
and obtained from Children’s Hospital Oakland Research
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Institute (CHORI, Oakland, CA). BAC DNA was isolated
using standard protocols and labeled directly with either
SpectrumGreen- or SpectrumOrange-conjugated dUTP
following the manufacturer’s instructions (Nick Translation Kit, catalog no.: 32-801300; Abbott Laboratories. IL).
Cot-I DNA (10 lL) was added for every 1 lg of labeled
probe to suppress repetitive sequences, and probes were
ethanol precipitated and resuspended in 50% Hybrisol
(50% formamide, 29saline-sodium citrate [SSC], 10%
dextran sulfate) (Abbott Laboratories).

Fluorescence in situ hybridization
Metaphase chromosomes were prepared using standard
cytogenetic protocols [13]. Fluorescence in situ hybridization (FISH) was performed with direct-labeled BAC probes
to map each inversion breakpoint. Probes were hybridized
in differentially labeled pairs (SpectrumGreen and SpectrumOrange [Vysis, Abbott Laboratories]). The telomeric
inversion breakpoint was mapped using BAC clones RP1189A16 (8q12.3-8q13.1), RP11-282D10 (8q13.1), RP11212P10 (8q13.1), RP11-271O1 (8q13.1), RP11-343B22
(8q13.2), and RP11-131P18 (8q13.2), and refined using
8q13.2 BAC clones RP11-396J6, RP11-566L6, RP11-664D7,
349K17, RP11-159C14, RP11-50A22, RP11-779P1, and
RP11-939K17. The centromeric inversion breakpoint was
mapped using RP11-726G23 (8p11.21-8p11.1), RP118790P20 (8q11.21), RP11-598P20 (8p11.21), RP11-1031I13
(8q11.1), and 1102L10 and 1130I3 (8q11.21).
Probes and chromosomes were codenatured at 72°C
for 2 min and hybridized overnight at 37°C in a HYBrite
apparatus (Abbott Molecular/Vysis). Slides were washed
in 50% formamide/29SSC at 37°C for 20 min and
29SSC at 37°C for 20 min. 4′,6′-diamidino-2-phenylindole hydrochloride (DAPI) was used as counterstain.
Hybridization results were assessed with a Zeiss Axioskop
2 epifluorescence microscope (Thornwood, NY) or an
Olympus BX51 microscope (Center Valley, PA), and
images were acquired with an Applied Imaging CytoVision cytogenetics workstation (Santa Clara, CA). A minimum of 10 metaphases was scored per hybridization.

Chromosomal microarray analysis
Chromosomal microarray analysis (CMA) studies were
performed to detect copy number variation (CNV) using
two different platforms. A custom high-resolution microarray was designed to target the DURS1 region (hg19;
chr8: 41,880,843-74,837,446). Overlapping probes of 50–
60 bases in length were tiled across the DURS1 region
beginning every ~10 bases (8p11.21-8q13.3) (Roche Nimblegen, Madison, WI). The experiment was performed
twice, using standard dye swap.
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An Illumina HumanOmniExpress BeadChip array composed of ~730 K single nucleotide polymorphisms (SNPs)
(Illumina, San Diego, CA) was performed following the
manufacturer’s directions. Data were evaluated and analyzed using Illumina’s GenomeStudio v2011.1 and Nexus
CN 7.0 Standard Edition software (updated on 19 April
2012). The Nexus analysis settings used for reporting
CNV(s) were as follows: SNP-FASST2 segmentation; significance threshold = 1.0E 9; max contiguous probe
spacing (Kbp) = 1000.0; min number of probes per segment = 15; Log-R thresholds were high gain = 0.41;
gain = 0.13; loss = 0.23; big loss = 1.1; sex chromosome gain (3:1) = 1.2; sex chromosome gain (4:1) = 1.7;
homozygous frequency threshold = 0.95; homozygous
value threshold = 0.8; heterozygous imbalance threshold = 0.4; minimum SNP probe density (Probes/
MB) = 0.0; regions minimum size (Kbp) = 50. The HumanOmniExpress BeadChip SNP CMA experiment was
carried out twice with similar results.

Results
Clinical history and examination
The proband was evaluated at 12.5 years of age. He was
born at term to a 15-year-old mother, with birth weight
of 3266 g (25–50 percentile) and length of 53 cm (75–90
percentile). He had neonatal apnea that resolved without
treatment and an otherwise unremarkable neonatal
course. On initial hearing evaluation left conductive hearing loss was reported, but repeat testing was normal. The
patient had numerous ear infections, frequent respiratory
infections, and asthma. Gastroesophageal reflux had been
diagnosed by pH probe. He underwent correction surgeries for right esotropia and cleft uvula and submucous
cleft palate.
Developmental testing revealed learning disabilities,
fine and gross motor delays, and articulation difficulties.
His WISC-III full-scale IQ was 90 when tested at 9 years
and at 11 years of age. He had been diagnosed with
panic disorder, anxiety disorder, attention deficit hyperactivity disorder, and adjustment disorder, and subsequently treated with Paroxetine and Methylphenidate.
Additional clinical investigations had included magnetic
resonance imaging of the brain, electroencephalogram,
sleep study, and abdominal sonogram, all reported as
normal. Echocardiography at age 11 was normal except
for false tendons in the left ventricle. DNA testing for
Fragile X and FISH for chromosome 22q11.2 microdeletion associated with velocardiofacial syndrome were
normal.
The biological mother was of Middle Eastern and Irish
ancestry. She completed 10th grade, obtained a general
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education diploma, and was reported to have normal cognition. Both she and her maternal half-sister were
reported to have pectus carinatum and leg length discrepancies. The boy’s biological father was of Puerto Rican
ancestry. Several paternal half-siblings were reported to
have motor delays but no additional details are available.
No relative was known to have DRS, cleft palate, or dysmorphic features.
On examination at 12.5 years of age, height was
163.25 cm (95th percentile), weight was 47.25 kg (75th
percentile), and head circumference was 53.9 cm (50th
percentile). Bilateral DRS was noted and was more severe
on the right (Fig. 2A and B). Dysmorphic features
included synophrys, almond-shaped palpebral fissures, flat
midface, high nasal bridge, malar hypoplasia, and inverted
W-shaped posterior hairline (Fig. 2A). Ears were prominent and measured 6.9 cm (90th percentile). Palm length
was 10.2 cm (85th percentile) and middle finger length
was 8.2 cm (97th percentile). He had slight asymmetric
pectus carinatum with hypoplastic right first rib noted on
radiograph, mild metatarsus adductus, flat feet, and wide
gap between the first and second toes. Pubic hair was
Tanner II, with testes measuring 5 mL.
(A)

Karyotype reveals a complex chromosome 8
inversion and marker chromosome
Chromosome analysis revealed a pericentric inversion of
chromosome 8 between the centromere and the long arm
and mosaicism for a supernumerary marker chromosome:
47,XY,inv(8)(p11.1q13.2),+mar[11]/46,XY,inv(8)(p11.1q13.2)
[9] (Fig. 3A). Multiplex fluorescence in situ hybridization
(M-FISH) confirmed that the marker chromosome was
derived from chromosome 8 (Fig. 3B). The parents were
not available for participation and, thus, their karyotypes
are not known.

Telomeric breakpoint reveals an intragenic
rearrangement of the chromosome 8 open
reading frame 34 gene (C8ORF34)
The proband’s transformed lymphoblasts were analyzed
by FISH to define the chromosome 8 inversion breakpoints. The 8p11.1 breakpoint was confirmed through
successive BAC hybridizations; the centromere marker,
CEP8, but no BAC clone was disrupted in mutant cells,
consistent with the original karyotype (Fig. 4A–C). The

(B)

Figure 2. Photographs of the proband. (A) Dysmorphic facial features included synophrys (which has been shaved), almond-shaped palpebral
fissures, flat midface, high nasal bridge, and malar hypoplasia. (A) and (B) Primary positions of gaze reveal bilateral DRS, more pronounced in the
right eye. Note relatively well aligned central gaze (A), with limited abduction of the right > left eye and narrowing of the right palpebral fissure
on attempted adduction (B). Up and downgaze are relatively preserved (B).
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Figure 3. Cytogenetic analysis of proband peripheral blood lymphocyte chromosomes. (A) GTG-banded karyotype revealed 47,XY,inv(8)
(p11.1q13.2),+mar[11]/46,XY,inv(8)(p11.1q13.2)[9]. (B) M-FISH confirms that the marker chromosome is derived from chromosome 8.
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Figure 4. FISH analysis of the proband’s lymphoblasts. FISH from two cells with cohybridization of CEP8 centromere probe (green), a telomeric
BAC probe for chromosome 8 (tel. marker; red) and BAC probes RP11-50A22 (red, left photo) or RP11-779P1 (red, right photo). Chromosomes
A, B, D, and E are enlarged and accompanied by schematics in the upper aspect of the figure. (Chromosome A) A normal chromosome 8 (chr.8)
shows the expected signal pattern for RP11-50A22. (Chromosome B) An inv(8) chromosome shows a split CEP8 signal (green) with the RP1150A22 signal (red) falling between the split CEP8 green signals, consistent with its inversion. This places the BAC centromeric to the inversion
breakpoint. (Chromosomes C) The mosaic chromosome 8 marker in each cell contains a CEP8 signal. (Chromosome D) A normal chromosome 8
(chr.8) shows the expected signal pattern for RP11-779P1. (Chromosome E) An inv(8) shows the split CEP8 signal (green) and an intact red signal
for RP11-779P1 telomeric to the split CEP8 signal, consistent with its normal orientation. (F) Schematic of the location of the BAC probes along
8q13.2. BAC probes denoted in blue were inverted, while BAC probes denoted in orange had a normal orientation. Thus, the translocation
breakpoint falls within the region defined by the start of RP11-50A22 and the end of RP11-865I6.2. This critical region (~293 Kb) encompasses
C8ORF34 on 8q13.2.

8q13.2 inversion breakpoint was defined by the inversion
of probe RP11-50A22 at chr8:69,471,542-69,634,621
(Fig. 4A and B) but not of the more telomeric probes
RP11-779P1 at chr8:69,621,417-69,803,905 (Fig. 4D, E)
and RP11-865I6.2 at chr8:69,760,977-69,764,998 (Fig. 4F).
Although inverted probe RP11-50A22 overlaps with noninverted probe RP11-779P1 by ~13 kb, we did not visualize a split of either BAC, suggesting the split occurs
within or near the region of overlap. In a structurally
normal chromosome 8, C8ORF34 maps to 8q13.2 and its
14 exons are transcribed in a centromeric (5′) to telomeric (3′) direction. The inverted BAC probe RP11-50A22
includes C8ORF34 exons 8–10, while the noninverted
BAC probe RP11-779P1 includes C8ORF34 exons 10–14.
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Thus, these data support an intragenic breakpoint of
C8ORF34 between exons 7–14, and map the telomeric
breakpoint maximum critical region to 293 kb between
hg19: chr8:69,471,542 and 69,764,998 defined by the start
of RP11-50A22 and the end of RP11-865I6.2 (Fig. 4F).

Chromosomal microarray analysis
demonstrates a complex mosaic duplication
of chromosome 8p11.1-q12.3
To define further the boundaries of the mosaic duplication arising from the marker chromosome, we undertook
CMA of the proband’s DNA. CMA analysis using the
custom comparative genomic hybridization (CGH) oligo-

ª 2013 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
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Figure 5. CMA results of chromosome 8 pericentromeric region and q arm using two different array platforms. (A) Nimblegen custom CGH
oligonucleotide microarray reveals a copy gain spanning 8q11.2-q12.1 containing 38 genes (hg19: chr8:51,490,197-60,554,196). This duplication
does not include the genes involved in the critical region of 8q12 microduplication syndrome CA8, RAB2A, CHD7, and CLVS1 highlighted in red.
(B) CMA result of chromosome 8q11.21-q12.3 using the Illumina HumanOmniExpress SNP-based array as interpreted by Nexus 7.0. (B-i)
Schematic of the chromosomal region annotated from top to bottom as follows: blue bar denotes the region shaded blue in the Log R ratio plot
in (B-ii); schematic of chromosomal banding; yellow and purple zygosity bars denote the regions shaded yellow and purple in the B-allele
frequency (BAF) plot in (B-iii–v); schematic of genes within the region with CA1, RAB2A, CHD7, and CLVS1 boxed in red; pink bars denote
common CNVs. (B-ii) Log R ratio plot in which each black dot represents the log intensity of the corresponding SNP. The region highlighted in
blue is consistent with a copy gain. (B-iii–v) BAF plot in which the black dots represent the genotype calls of the SNPs in (B-ii). SNPs that plot at
either 0 or 1 are homozygous, SNPs that plot at 0.5 are heterozygous, while SNPs that plot at 0.33 and 0.66 have an allelic imbalance. (B-iii)
Yellow rectangle highlights SNPs from 43.5 to 51 Mb with LOH (aside from five SNPs showing the pattern of allelic imbalance). The combined
information from the overlapping Log-R-ratio and BAF plots is atypical for copy gains and might reflect a UPD. (B-iv and v) Purple rectangles
highlight SNPs from 51 to 63.5 Mb with allelic imbalance which is characteristic of a copy gain. The drop in the Log R ratio between B-iv and B-v
may reflect a reduction in the level of mosaicism.

nucleotide based microarray shows a 9 Mb copy gain
spanning 8q11.2-q12.1 (hg19: chr8:51,488, 197-60,554,
196); the duplicated region contains 38 genes but excludes
CA8, RAB2A, CHD7, and CLVS1 (Fig. 5A).
CMA using the SNP-based array revealed a larger and
more complex duplication pattern which encompasses the
region identified by the oligonucleotide array; the region
spans 8p11.1-q12.3 and contains 56 genes (hg19:
chr8:43,460,491-63,696,218) including CA8, RAB2A, CHD7,
and CLVS1 (Fig. 5B-i–v). Notably, this region contains several contiguous but distinctive patterns of duplication. The
pericentromeric area, highlighted in yellow (Fig. 5B-iii), has
a Log R ratio of 0.39 within the smaller region on 8p11.1,
but a ratio of only 0.15 within the larger region on 8q11.1-

ª 2013 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

8q11.21. More remarkably, this region does not harbor the
allelic imbalance predicted within a region of duplication,
but instead reveals loss of heterozygosity (LOH). In contrast, the allele frequencies within the regions highlighted in
purple (Fig. 5B-iv, v) harbor the anticipated allelic imbalance. In addition, the first purple region (Fig. 5B-iv) has a
Log R ratio of 0.22 and corresponds closely to the region
of duplication detected by the oligonucleotide array
(Fig. 5A). Within the second region highlighted in purple
(Fig. 5B-v) the Log R ratio falls to 0.15. Thus, the regions
labeled 5B-ii and 5B-v both have Log R ratios very close to
minimum threshold for copy number gain set at 0.13, and
this might account for why the mosaicism was not detected
by the oligonucleotide array.
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Discussion
The 8q12-8q13 DURS1 locus is defined by two patients
with syndromic DRS harboring deletions beginning at
8q12 and extending in the telomeric direction [4, 5] and
one patient with a reciprocal translocation disrupting
CPA6 on 8q13.2 [6, 7]. While all three patients had DRS,
their accompanying syndromic features were quite variable. The definition of the DURS1 locus was then
expanded by reports of three patients with DRS and 8q12
microduplications who shared syndromic features of
DRS, dysmorphism, neonatal hypotonia, and motor
developmental delay [9–11]. Analyses of studies performed to date (Fig. 1) reveal that the deleted and the
duplicated chromosomal regions within the DURS1 locus
are nonoverlapping.
Herein, we report a 12.5-year-old boy with syndromic
DRS whose analysis further highlights the complexity of
cytogenetic abnormalities that can occur at the DURS1DRS locus. We find that he has a unique constellation of
features associated with DRS, and has both a chromosome 8 inversion that transposes highly repetitive centromeric DNA and multiple 8q genes (8p11.1-8q13.2), and a
complex mosaic supernumerary marker chromosome
containing 8p11.1-8q12.3 material.
Using FISH, we successfully mapped the telomeric inversion breakpoint to a 293 Kb interval within C8ORF34.
C8ORF34 is a cDNA isolated from a human vestibular
library which encodes an uncharacterized protein containing a putative cAMP-dependent protein kinase regulatory
subunit expressed in adult brain, eye, ear, pituitary gland,
thymus, kidney, and stomach (UCSC genome browser
http://genome.ucsc.edu and Stanford SOURCE search gene
report, http://source.stanford.edu). Thus, alteration or loss
of C8ORF34 function in brain and eye could potentially
contribute to the patient’s DRS and intellectual and social
disabilities. The translocation disrupting CPA6 [7] and the
inversion disrupting C8ORF34 (this report) support disruption of these genes, or regulatory elements, in DURS1DRS. These genes are also deleted in the patient reported
with branchiootorenal syndrome without DRS [8], however, suggesting that simply deleting these genes is not adequate to cause DRS, or that DRS is not fully penetrant.
The chromosome 8 inversion also transposes highly repetitive centromeric DNA to the long arm of chromosome 8.
We are not aware of phenotypic sequelae from germline
changes in centromeric repetitive DNA sequence. There is,
however, data suggesting that repetitive elements can have
epigenetic influences on gene expression [14, 15]. Thus,
transposition of centromeric DNA may also contribute to
the proband’s phenotype.
Concordant with our findings from the karyotype and
FISH, interpretation of data from the two different CMA
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platforms is not straightforward, highlighting the complexity of the molecular mechanisms that have resulted
in the apparent chromosomal rearrangement. While the
custom CGH microarray demonstrates an 8q11.2-q12.1
duplication that does not include the four genes found
to be in the 8q12 microduplication syndrome critical
region, the SNP-based array reveals a larger region of
duplication that includes these, as well as many
additional genes. It has been reported that SNP-based
arrays can detect subtle changes, such as low level mosaicism, that are missed on CGH [16], and thus we are
confident that the extended duplicated region encompassing the 8q12 microduplication region in this patient is
real. However, we cannot provide an explanation for the
decrease in the level of mosaicism within the most telomeric portion of the duplicated region, nor for the LOH
within the pericentromeric region. LOH regions identified from SNP-based arrays usually indicate consanguinity, uniparental disomy (UPD), or true copy number
loss. We are unaware of a family history compatible with
consanguinity, and no excess of LOH regions were
observed in the CMA at the whole genome level. Notably, however, it has been suggested that at least one third
of UPD cases emerge in connection with or due to a
chromosomal rearrangement [17]. As the LOH region
identified in the q arm shows a borderline Log R ratio
for a copy gain, it is possible that the region is actually
in a euploid state.
The proband shares some dysmorphic features and
motor developmental delay with patients previously
described with the germline 8q12 microduplication syndrome, suggesting that duplication of CA8, RAB2A,
CHD7, and/or CLVS1 may contribute to DRS. He does
not, however, share their heart and kidney malformations,
he has less severe intellectual disabilities, and he has additional dysmorphisms, including a submucous cleft palate,
not present in the previously described patients. These
differences may reflect the low level of mosaic duplication
in the patient or effects from the additional regions of
duplication and inversion. Moreover, a fifth patient with
an 8q12 microduplication encompassing these genes was
reported to not have DRS [12], Thus, DRS may not be a
fully penetrant feature of the 8q12 microduplication syndrome, or may arise from duplication of the 572 Kb
region identified in the four patients with DRS but not in
the patient without DRS (Fig 1). This region (hg19:
chr8:60,219,746-60,792,079) is currently annotated by the
UCSC Genome Browser to contain spliced ESTs and long
noncoding RNAs but no protein-coding genes.
In summary, these data suggest that the DURS1 locus
could result in DRS by dosage effect in the region of 8q1,
through deletion on 8q13 and/or a duplication of 8q12,
or through alterations in gene expression arising from
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the inversion breakpoints or transposition of repetitive
centromeric sequence. Thus, this case highlights the complexity of human disorders, and the potential requirement
for multiple methods (including cytogenetics and different chromosomal microarray platforms) to gain insight
into genotype–phenotype correlation, and ultimately into
molecular mechanisms that underlie human disease.
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